Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06XSB
|
||||
Former ID |
DIB010315
|
||||
Drug Name |
870086 (topical, atopic dermatitis), GlaxoSmithKline
|
||||
Synonyms |
GW-870086-X (topical, atopic dermatitis), GlaxoSmithKline
|
||||
Company |
GlaxoSmithKline plc
|
||||
Target and Pathway | |||||
Target(s) | Glucocorticoid receptor | Target Info | Agonist | [532254] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
NetPath Pathway | IL2 Signaling Pathway | ||||
TCR Signaling Pathway | |||||
References | |||||
Ref 522149 | ClinicalTrials.gov (NCT00549497) A Randomized Study Evaluating Steroid Hormone Levels, Safety And Tolerability Of GW870086X In Healthy Volunteers. U.S. National Institutes of Health. | ||||
Ref 523364 | ClinicalTrials.gov (NCT01299610) A Study to Test the Effect of 2 Different Doses of Topical GW870086X on Atopic Dermatitis Also Including a Postive Control and a Placebo. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.